Health-related quality of life of men treated with hormonal therapy for prostate cancer
Date
2019
Authors
Sichinga, Tikondwe Kaponda
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
HRQoL is the central focus of treatment and care for cancer patients regardless of
treatment and whether the goal of treatment is cure, control or palliation.
Research question: What is the HRQoL of men treated with hormonal therapy for
prostate cancer at an academic hospital in Gauteng?
Aim of the study: The study aimed to describe the HRQoL of men treated with
hormonal therapy for prostate cancer at an academic hospital in Gauteng.
Research Design: A cross-sectional design was used. A sample of 113 respondents
were recruited using a convenience sampling. The European Organisation for
Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
and prostate-specific (EORTC QLQ - PR25) instruments were used for data
collection. Data were analysed using STATA computer programme.
Results: The HRQoL was affected by the disease and treatment side effects. All the
domains except role functioning were compromised.
Recommendations: Nurses are encouraged to conduct accurate assessment to
manage patients holistically.
Description
A research report submitted to the Faculty of Health Sciences, University of the
Witwatersrand, Johannesburg, in partial fulfilment of the requirements for the degree
of Master of Science in Nursing
Johannesburg, 2019